First of all, I would like to express my deepest gratitude to our KSPST (Korean Society of Pharmaceutical Sciences and Technology) members for their devoted contribution, generous sponsorship and support. I sincerely wish you all health and all the things you desire, and your family full of peace and happiness in 2020.
Inherited its founding spirit, the KSPST, founded in 1971 with the aim of developing pharmaceutics and contributing to human welfare, has led the breakthrough development and innovation of science and technology in Pharmaceutics, the industry-academic cooperation with pharmaceutical industry and the cultivation of highly qualified professionals for the past half century, which has actually contributed to the development of Pharmacy and pharmaceutical industry in Korea. In addition, the KSPST has been growing as a full-fledged professional academic society which is well-versed in the role of providing academic foundations and innovative technologies in a wide range of fields ranging from full-cycle new drug and drug development research, commercialization technology development, drug regulatory science and policy, and social participation as well as has been enhancing its international standing and leaping into a global academic society by expanding academic ties and interactions with other leading international societies. I believe that these remarkable growth and fruits are not only the result of the constant contributions and dedication of our members, but also the generous encouragement and support of the Korean government and pharmaceutical industry.
There is no doubt that Korea has already entered the ranks of advanced pharmaceutical countries in terms of drug R&D capability, regulatory system and policy, and Korean pharmaceutical industry will play a pivotal role in Korean economic development as one of next-generation growth engines. Accordingly, as a leading academic society that is in charge of the construction of a pharmaceutical powerhouse, the role of the KSPST will be very significant. Globally, there are tougher pharmaceutical regulations and demand for high quality, infinite competition in the development of new drugs and innovative pharmaceutical technologies, rapid changes in the international pharmaceutical environment, and the wave of the fourth industrial revolution and artificial intelligence. The key role and support of our KSPST are urgently needed in preparing appropriate drug administration policy, international cooperation and harmony, and strategy of pharmaceutical industry to cope with this era.
In order to revive these roles and demands of our KSPST, we need to prepare a strong leap once again. We all need to work together to expand the framework and build capacity to present academic foundations and substantive grounds for solving the problems of pharmaceutical industry and to lead the exchange of advanced science and technology in other related disciplines and industries. Our KSPST should take the lead in linking academic research achievements and development efforts in the pharmaceutical industry and utilizing them in the pharmaceutical industry by dealing with and discussing the global advanced technologies for drug development, trend of international regulatory sciences, scientific basis of government drug policy, issues and global entry difficulties in pharmaceutical field, and activation and industrial cooperation of academic research through KSPST domestic and international academic activities and events. In order to promote these activities, all members of our KSPST are urged to participate voluntarily and actively cooperate.
Our 2020 KSPST board of directors and executive officers promise to devote passionately and do our best for the new leap and continuous development of KSPST. We wish you all the best, and thank you very much.
Euichaul Oh, Ph.D.
President, The Korean Society of Pharmaceutical Sciences and Technology